Paratek Pharmaceuticals, Inc. (PRTK)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 1.9000 |
| Open | 1.9300 |
| Bid | 1.6900 x 1100 |
| Ask | 1.9000 x 1800 |
| Day's range | 1.8400 - 1.9500 |
| 52-week range | 1.6800 - 11.2400 |
| Volume | |
| Avg. volume | 555,096 |
| Market cap | 93.853M |
| Beta (5Y monthly) | 1.50 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.0970 |
| Earnings date | 22 Feb 2022 - 28 Feb 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 31 Oct 2014 |
| 1y target est | 18.50 |
- Motley Fool
Paratek Pharmaceuticals (PRTK) Q1 2022 Earnings Call Transcript
Participants on today's call are Evan Loh, M.D, chief executive officer; Adam Woodrow, president and chief commercial officer; and Randy Brenner, chief development and regulatory officer. Michael Bigham, executive chairman, and I will also be available for questions.
- Simply Wall St.
Paratek Pharmaceuticals, Inc.'s (NASDAQ:PRTK) Profit Outlook
We feel now is a pretty good time to analyse Paratek Pharmaceuticals, Inc.'s ( NASDAQ:PRTK ) business as it appears the...
- Motley Fool
Paratek Pharmaceuticals (PRTK) Q4 2021 Earnings Call Transcript
It is now my pleasure to introduce your host, Sarah Higgins, vice president of finance, controller, and principal accounting officer. Participants on today's call are Evan Loh, chief executive officer; Adam Woodrow, president and chief commercial officer; and Randy Brenner, chief development and regulatory officer.
© 2022 Yahoo. All rights reserved.
